Barriers to Molecular Research in Gliomas: Implications for Precision Medicine in Resource-Limited Nations - Scorecard - MDSpire

Barriers to Molecular Research in Gliomas: Implications for Precision Medicine in Resource-Limited Nations

  • By

  • Pablo S. Paolinelli

  • Tomas Saavedra Azcona

  • Florencia B. Casto

  • Ezequiel Jungberg

  • Nicolás Tilano

  • William A. Blettler

  • Joan S. Pazos

  • Silvina Dell’Era

  • Clara Lynch

  • Miguel Villaescusa

  • Pedro Plou

  • Pablo Ajler

  • April 20, 2026

  • 0 min

Share

Clinical Scorecard: Barriers to Molecular Research in Gliomas: Implications for Precision Medicine in Resource-Limited Nations

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with gliomas undergoing elective tumor surgery in resource-limited settings, emphasizing barriers to care.
Care Setting

Key Highlights

  • highlight

Guideline-Based Recommendations

Diagnosis

    Management

    • Implement personalized therapy based on molecular profiling when available, including examples such as targeted therapies or immunotherapies.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Access to molecular testing is crucial for accurate diagnosis and effective treatment planning, with noted barriers in resource-limited settings.

        Clinical Best Practices

        • recommendation

        References

        Original Source(s)

        Related Content